ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,064.20
0.91%
US Tech 100
17,186.80
1.93%
다우존스 지수
38,225.66
0.85%
Bitcoin
59,261.50
1.76%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Cullinan Therapeutics Inc (CGEM)

  7. Cullinan Therapeutics Inc (CGEM) 뉴스

CGEM Cullinan Therapeutics Inc

27.58
-0.52 (-1.85%)
시간외 거래
최종 업데이트: 06:39:18
15분 지연
기업명 주식 심볼 시장 주식 타입
Cullinan Therapeutics Inc CGEM 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.52 -1.85% 27.58 06:39:18
개장가 저가 고가 종가 전일 종가
28.22 26.73 28.22 27.58 28.10
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
29/04/202420:00GLOBECullinan Therapeutics Announces Appointment of Mary Kay..
24/04/202423:09GLOBECullinan Therapeutics to Present Clinical Data from Phase 1..
16/04/202420:00GLOBECullinan Therapeutics Announces Strategic Expansion into..
16/04/202419:59GLOBECullinan Therapeutics Announces Oversubscribed $280 million..
14/03/202420:00GLOBECullinan Oncology Provides Corporate Update and Reports..
01/03/202421:00GLOBECullinan Oncology Announces U.S. FDA Clearance of..
27/02/202422:00GLOBECullinan Oncology to Participate in Upcoming Investor..
24/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202411:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/02/202411:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/02/202406:43EDGAR2Form 144 - Report of proposed sale of securities
31/01/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/01/202406:27EDGAR2Form 144 - Report of proposed sale of securities
25/01/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/01/202406:18EDGAR2Form 144 - Report of proposed sale of securities
09/01/202406:15EDGAR2Form 8-K/A - Current report: [Amend]
08/01/202423:12EDGAR2Form 8-K - Current report
23/12/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202306:53GLOBECullinan Oncology to Present at the 42nd Annual J.P. Morgan..
15/12/202306:30GLOBECullinan Oncology Announces First Patient Dosed in Phase 1..
14/12/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202321:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202321:10EDGAR2Form 8-K - Current report
08/11/202321:00GLOBECullinan Oncology Provides Corporate Update and Reports..
04/11/202301:01GLOBECullinan Oncology to Present Data Demonstrating Progress..
30/10/202321:00GLOBECullinan Oncology to Participate in Upcoming Investor..
06/09/202321:00GLOBECullinan Oncology to Participate in Upcoming Investor..
10/08/202320:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202320:07EDGAR2Form 8-K - Current report
10/08/202320:00GLOBECullinan Oncology Provides Corporate Update and Reports..
09/08/202320:00GLOBECullinan Oncology Announces First Patient Dosed in Phase 1..
04/08/202305:15PRNUSREZILIENT3 Global First-Line Trial of Zipalertinib Launched..
31/07/202321:00GLOBECullinan Oncology to Participate in Upcoming Investor..
06/07/202310:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/05/202306:00GLOBECullinan Oncology to Present First Monotherapy Clinical Data..
12/05/202305:01GLOBECullinan Oncology Provides Corporate Update and Reports..

최근 히스토리

NASDAQ
CGEM
Cullinan Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유